Free Trial
LON:IMM

ImmuPharma (IMM) Share Price, News & Analysis

ImmuPharma logo
GBX 2.17 -0.08 (-3.56%)
As of 07/4/2025

About ImmuPharma Stock (LON:IMM)

Key Stats

Today's Range
2.12
2.20
50-Day Range
2.13
3.72
52-Week Range
0.85
7.40
Volume
900,084 shs
Average Volume
7.03 million shs
Market Capitalization
£9.22 million
P/E Ratio
N/A
Dividend Yield
0.77%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive IMM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmuPharma and its competitors with MarketBeat's FREE daily newsletter.

IMM Stock News Headlines

A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
ImmuPharma PLC (25I.MU)
ImmuPharma Targets Global Partnerships at Key Biotech Events
See More Headlines

IMM Stock Analysis - Frequently Asked Questions

ImmuPharma's stock was trading at GBX 1.18 on January 1st, 2025. Since then, IMM stock has increased by 84.2% and is now trading at GBX 2.17.

ImmuPharma plc (LON:IMM) released its quarterly earnings results on Monday, May, 19th. The company reported ($0.60) earnings per share for the quarter. ImmuPharma had a negative trailing twelve-month return on equity of 131.41% and a net margin of 3,519.56%.

Shares of IMM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that ImmuPharma investors own include Castleton Technology (CTP), 4D pharma (DDDD), Motif Bio (MTFB), Nikola (NKLA), Thor Energy (THR), Aminex (AEX) and GSK (GSK).

Company Calendar

Last Earnings
5/19/2025
Today
7/05/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:IMM
CIK
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£2.51 million
Net Margins
3,519.56%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
-£71.31 thousand
Cash Flow
GBX 0.11 per share
Price / Cash Flow
20.50
Book Value
GBX 0.65 per share
Price / Book
3.36

Miscellaneous

Free Float
N/A
Market Cap
£9.22 million
Optionable
Not Optionable
Beta
1.53
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (LON:IMM) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners